We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
Elekta (EKTA-B.ST) announced today that it will establish a permanent office in Cairo, Egypt, to address the shortage of radiotherapy delivery systems and software solutions that play an integral part in treating cancer and brain disorders.
Bipolar disorder, also known as manic-depressive illness, is a brain disorder that causes unusual shifts in mood, energy, activity levels and the ability to carry out day-to-day tasks, according to the National institute of Mental Health.
BioMarin announced that the Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion for the company’s Marketing Authorization Application (MAA) for Brineura (cerliponase alfa) to treat children with Neuronal Ceroid Lipofuscino